Anti-Cancer Effect of Ginsenoside F2against Glioblastoma Multiforme in Xenograft Model in SD Rats
Open Access
- 11 January 2012
- journal article
- Published by Elsevier BV in Journal of Ginseng Research
- Vol. 36 (1), 86-92
- https://doi.org/10.5142/jgr.2012.36.1.86
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Ginsenoside Rd in Experimental Stroke: Superior Neuroprotective Efficacy with a Wide Therapeutic WindowNeurotherapeutics, 2011
- Ginsenoside Rh2 induces Bcl‐2 family proteins‐mediated apoptosis in vitro and in xenografts in vivo modelsJournal of Cellular Biochemistry, 2010
- Potential therapeutic implications of cancer stem cells in glioblastomaBiochemical Pharmacology, 2010
- Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomasLaboratory Investigation, 2008
- Diffuse glioma growth: a guerilla warActa Neuropathologica, 2007
- CD133+ Renal Progenitor Cells Contribute to Tumor AngiogenesisThe American Journal of Pathology, 2006
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Identification of human brain tumour initiating cellsNature, 2004
- Elevated Levels of Mr92,000 Type IV Collagenase during Tumor Growthin VivoBiochemical and Biophysical Research Communications, 1998
- Main Ginseng Saponin Metabolites Formed by Intestinal BacteriaPlanta Medica, 1996